These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11586113)

  • 21. Topiramate effects on the EEG and alertness in healthy volunteers: a different profile of antiepileptic drug neurotoxicity.
    Salinsky M; Storzbach D; Oken B; Spencer D
    Epilepsy Behav; 2007 May; 10(3):463-9. PubMed ID: 17337249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
    Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
    Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study.
    Baker GA; Currie NG; Light MJ; Schneiderman JH;
    Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate in refractory epilepsy: a prospective observational study.
    Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible hemiparesis associated with the use of topiramate.
    Patel H; Asconapé JJ; Garg BP
    Seizure; 2002 Oct; 11(7):460-3. PubMed ID: 12237075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Topiramate (Topamax). Pharmacological characteristics and current use in epilepsy treatment].
    Bauer J; Schwalen S
    Nervenarzt; 2000 Jun; 71(6):495-501. PubMed ID: 10919147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
    Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
    Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmarketing experience with topiramate and cognition.
    Tatum WO; French JA; Faught E; Morris GL; Liporace J; Kanner A; Goff SL; Winters L; Fix A;
    Epilepsia; 2001 Sep; 42(9):1134-40. PubMed ID: 11580760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life.
    Kerr MP; Baker GA; Brodie MJ
    Epilepsy Behav; 2005 Nov; 7(3):472-80. PubMed ID: 16140593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topiramate titration and tolerability.
    Biton V; Edwards KR; Montouris GD; Sackellares JC; Harden CL; Kamin M;
    Ann Pharmacother; 2001 Feb; 35(2):173-9. PubMed ID: 11215835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate.
    Glauser TA
    Epilepsia; 1999; 40 Suppl 5():S71-80. PubMed ID: 10530697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate: New preparation. Helpful in refractory partial epilepsy.
    Prescrire Int; 1999 Feb; 8(39):3-5. PubMed ID: 10557563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of topiramate in patients with epilepsy and intellectual deficits].
    Huber B
    Nervenarzt; 2002 Jun; 73(6):525-32. PubMed ID: 12242999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.
    Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G
    Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate as a new antiepileptic drug in epileptic children in Iran.
    Fallah R
    Indian J Pediatr; 2006 Dec; 73(12):1073-5. PubMed ID: 17202632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.